These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31614739)

  • 1. PPARγ and Cognitive Performance.
    d'Angelo M; Castelli V; Catanesi M; Antonosante A; Dominguez-Benot R; Ippoliti R; Benedetti E; Cimini A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIT2: responsible and susceptible gene for neurological and psychiatric disorders.
    Daneshmandpour Y; Darvish H; Emamalizadeh B
    Mol Genet Genomics; 2018 Aug; 293(4):785-792. PubMed ID: 29860660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator activated receptor gamma (PPARγ) as a therapeutic target for improvement of cognitive performance in Fragile-X.
    Farshbaf MJ; Ghaedi K; Shirani M; Nasr-Esfahani MH
    Med Hypotheses; 2014 Mar; 82(3):291-4. PubMed ID: 24456944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression.
    Kariharan T; Nanayakkara G; Parameshwaran K; Bagasrawala I; Ahuja M; Abdel-Rahman E; Amin AT; Dhanasekaran M; Suppiramaniam V; Amin RH
    Neurobiol Aging; 2015 Mar; 36(3):1451-61. PubMed ID: 25510319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is telomere length a biomarker of neurological disorders?
    Thanseem I; Viswambharan V; Poovathinal SA; Anitha A
    Biomark Med; 2017 Sep; 11(9):799-810. PubMed ID: 30669856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and the regulation of cognition and attention.
    Nieoullon A
    Prog Neurobiol; 2002 May; 67(1):53-83. PubMed ID: 12126656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARβ/δ and γ in a rat model of Parkinson's disease: possible involvement in PD symptoms.
    Falcone R; Florio TM; Di Giacomo E; Benedetti E; Cristiano L; Antonosante A; Fidoamore A; Massimi M; Alecci M; Ippoliti R; Giordano A; Cimini A
    J Cell Biochem; 2015 May; 116(5):844-55. PubMed ID: 25530507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroplastin in Neuropsychiatric Diseases.
    Lin X; Liang Y; Herrera-Molina R; Montag D
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism and Parkinson's disease.
    Woodward G
    Med Hypotheses; 2001 Feb; 56(2):246-9. PubMed ID: 11425297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease.
    Landreth G
    Curr Alzheimer Res; 2007 Apr; 4(2):159-64. PubMed ID: 17430241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.
    Kaundal RK; Sharma SS
    Drug News Perspect; 2010 May; 23(4):241-56. PubMed ID: 20520853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease?
    Johnson S
    Med Hypotheses; 2001 May; 56(5):641-5. PubMed ID: 11388783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.
    Calabresi P; Picconi B; Parnetti L; Di Filippo M
    Lancet Neurol; 2006 Nov; 5(11):974-83. PubMed ID: 17052664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases.
    Mohammadi A; Amooeian VG; Rashidi E
    Curr Gene Ther; 2018; 18(1):45-63. PubMed ID: 29512462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic networks in intellectual disabilities.
    van Bokhoven H
    Annu Rev Genet; 2011; 45():81-104. PubMed ID: 21910631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent.
    Chiang MC; Cheng YC; Nicol CJ; Lin CH
    Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease.
    Sragovich S; Merenlender-Wagner A; Gozes I
    Bioessays; 2017 Nov; 39(11):. PubMed ID: 28940660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.
    Katsouri L; Blondrath K; Sastre M
    IUBMB Life; 2012 Dec; 64(12):958-64. PubMed ID: 23129362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of cognitive decline in Parkinson's disease.
    Lin CH; Wu RM
    Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.